A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

NCT03751657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin icodec
DRUG: Placebo (insulin 287)
DRUG: Metformin
DRUG: Dipeptidyl peptidase-4 inhibitors
DRUG: Insulin glargine
DRUG: Placebo (insulin glargine)

Sponsor

Novo Nordisk A/S